Navigation

TA106 Hepatitis C - peginterferon alfa and ribavirin: information for the public

Some advice on using peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C has been replaced by NICE technology appraisal guidance 200 and NICE technology appraisal guidance 300. See Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C and Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people for more details.

This page was last updated: 25 November 2013

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.